Free Trial

BrainsWay (BWAY) Competitors

$6.16
-0.07 (-1.12%)
(As of 06/21/2024 ET)

BWAY vs. XAIR, DCTH, ANIK, TMCI, OSUR, SGHT, NVRO, CERS, TCMD, and GUTS

Should you be buying BrainsWay stock or one of its competitors? The main competitors of BrainsWay include Beyond Air (XAIR), Delcath Systems (DCTH), Anika Therapeutics (ANIK), Treace Medical Concepts (TMCI), OraSure Technologies (OSUR), Sight Sciences (SGHT), Nevro (NVRO), Cerus (CERS), Tactile Systems Technology (TCMD), and Fractyl Health (GUTS). These companies are all part of the "surgical & medical instruments" industry.

BrainsWay vs.

BrainsWay (NASDAQ:BWAY) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, community ranking, institutional ownership, valuation, profitability, analyst recommendations, earnings, media sentiment and risk.

30.1% of BrainsWay shares are held by institutional investors. Comparatively, 31.5% of Beyond Air shares are held by institutional investors. 19.0% of BrainsWay shares are held by insiders. Comparatively, 19.0% of Beyond Air shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, BrainsWay and BrainsWay both had 1 articles in the media. BrainsWay's average media sentiment score of 0.50 beat Beyond Air's score of 0.00 indicating that BrainsWay is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrainsWay
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Beyond Air
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

BrainsWay has higher revenue and earnings than Beyond Air. BrainsWay is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrainsWay$31.78M3.23-$4.20M-$0.09-68.44
Beyond AirN/AN/A-$55.82M-$2.13-0.58

BrainsWay presently has a consensus target price of $13.00, suggesting a potential upside of 111.04%. Beyond Air has a consensus target price of $9.00, suggesting a potential upside of 625.81%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts plainly believe Beyond Air is more favorable than BrainsWay.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrainsWay
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Beyond Air
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Beyond Air has a net margin of 0.00% compared to BrainsWay's net margin of -4.83%. BrainsWay's return on equity of -3.98% beat Beyond Air's return on equity.

Company Net Margins Return on Equity Return on Assets
BrainsWay-4.83% -3.98% -2.68%
Beyond Air N/A -199.90%-106.00%

BrainsWay has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500. Comparatively, Beyond Air has a beta of 0.01, meaning that its share price is 99% less volatile than the S&P 500.

BrainsWay received 19 more outperform votes than Beyond Air when rated by MarketBeat users. However, 68.75% of users gave Beyond Air an outperform vote while only 64.95% of users gave BrainsWay an outperform vote.

CompanyUnderperformOutperform
BrainsWayOutperform Votes
63
64.95%
Underperform Votes
34
35.05%
Beyond AirOutperform Votes
44
68.75%
Underperform Votes
20
31.25%

Summary

BrainsWay beats Beyond Air on 8 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BWAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BWAY vs. The Competition

MetricBrainsWaySurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$103.82M$3.93B$5.26B$8.42B
Dividend YieldN/A1.81%2.84%4.09%
P/E Ratio-68.449.63110.8414.83
Price / Sales3.2377.752,176.6365.77
Price / CashN/A46.8934.6330.94
Price / Book2.464.134.764.19
Net Income-$4.20M$4.42M$111.12M$216.53M
7 Day Performance0.49%0.06%-2.22%-1.22%
1 Month Performance15.14%-1.30%-3.07%-2.31%
1 Year Performance167.83%-18.37%-2.77%0.05%

BrainsWay Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XAIR
Beyond Air
3.1839 of 5 stars
$1.31
+4.0%
$9.33
+612.5%
-78.3%$47.21MN/A-0.6298Upcoming Earnings
DCTH
Delcath Systems
1.3141 of 5 stars
$8.13
+6.4%
$20.20
+148.5%
+49.8%$225.93M$2.07M-3.0776Gap Up
ANIK
Anika Therapeutics
2.6775 of 5 stars
$25.98
+0.2%
$30.50
+17.4%
-2.5%$379.05M$166.66M-4.95357Short Interest ↓
Positive News
TMCI
Treace Medical Concepts
3.0677 of 5 stars
$5.86
-2.8%
$12.21
+108.4%
-77.0%$363.38M$187.12M-6.66516Positive News
OSUR
OraSure Technologies
2.6295 of 5 stars
$4.54
+6.8%
$6.63
+45.9%
-14.6%$335.78M$405.47M15.13638Positive News
High Trading Volume
SGHT
Sight Sciences
0.3607 of 5 stars
$6.36
-0.6%
$4.70
-26.1%
-17.4%$316.47M$81.06M-5.68214
NVRO
Nevro
1.2717 of 5 stars
$8.56
-2.8%
$19.46
+127.4%
-65.9%$314.41M$425.17M-3.741,215Gap Down
CERS
Cerus
2.3728 of 5 stars
$1.69
flat
$3.83
+126.8%
-33.2%$312.46M$156.37M-9.94625
TCMD
Tactile Systems Technology
3.0937 of 5 stars
$11.13
-3.1%
$30.00
+169.5%
-53.5%$264.45M$274.42M9.28992Positive News
GUTS
Fractyl Health
0 of 5 stars
$5.36
-0.4%
$22.00
+310.4%
N/A$256.74M$120,000.000.00102News Coverage
High Trading Volume

Related Companies and Tools

This page (NASDAQ:BWAY) was last updated on 6/23/2024 by MarketBeat.com Staff

From Our Partners